216 related articles for article (PubMed ID: 37973393)
1. Erectile response profiles of men using PDE5 inhibitors combined with intracavernosal injections as part of a penile rehabilitation program after radical prostatectomy.
Furtado TP; Miranda EP; Deveci S; Jenkins L; Narus J; Nelson C; Mulhall JP
J Sex Med; 2023 Dec; 21(1):29-32. PubMed ID: 37973393
[TBL] [Abstract][Full Text] [Related]
2. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function.
Mulhall J; Land S; Parker M; Waters WB; Flanigan RC
J Sex Med; 2005 Jul; 2(4):532-40; discussion 540-2. PubMed ID: 16422848
[TBL] [Abstract][Full Text] [Related]
3. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
[TBL] [Abstract][Full Text] [Related]
4. Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection?
Yang Y; Hu JL; Ma Y; Wang HX; Chen Z; Xia JG; Wang YX; Huang YR; Chen B
Int J Impot Res; 2012 Sep; 24(5):191-5. PubMed ID: 22592761
[TBL] [Abstract][Full Text] [Related]
5. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
[TBL] [Abstract][Full Text] [Related]
7. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
Nandipati K; Raina R; Agarwal A; Zippe CD
Int J Impot Res; 2006; 18(5):446-51. PubMed ID: 16482200
[TBL] [Abstract][Full Text] [Related]
8. Penile rehabilitation following radical prostatectomy: predicting success.
Müller A; Parker M; Waters BW; Flanigan RC; Mulhall JP
J Sex Med; 2009 Oct; 6(10):2806-12. PubMed ID: 19732314
[TBL] [Abstract][Full Text] [Related]
9. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
Sung HH; Ahn JS; Kim JJ; Choo SH; Han DH; Lee SW
Andrology; 2014 Jan; 2(1):45-50. PubMed ID: 24194017
[TBL] [Abstract][Full Text] [Related]
10. Delineating patient errors in an intracavernosal injection program.
Furtado TP; Teloken PE; Ortega Y; Narus J; Wolchasty NP; Mulhall JP
J Sex Med; 2024 May; 21(6):529-532. PubMed ID: 38660738
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Controlled, 3-Arm Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function After Radical Prostatectomy.
Miranda EP; Benfante N; Kunzel B; Nelson CJ; Mulhall JP
J Sex Med; 2021 Feb; 18(2):423-429. PubMed ID: 33303389
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database.
Lui JL; Shaw NM; Abbasi B; Hakam N; Breyer BN
Andrology; 2023 Oct; 11(7):1408-1417. PubMed ID: 36905319
[TBL] [Abstract][Full Text] [Related]
14. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
16. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy.
Bai WJ; Li HJ; Dai YT; He XY; Huang YR; Liu JH; Sorsaburu S; Ji C; Jin JJ; Wang XF
Asian J Androl; 2015; 17(1):61-7. PubMed ID: 25370206
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for erectile dysfunction in patients with diabetes mellitus.
Basu A; Ryder RE
Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
[TBL] [Abstract][Full Text] [Related]
18. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
Mazzola CR; Deveci S; Teloken P; Mulhall JP
J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the intracavernosal injection platelet-rich plasma in addition to daily oral tadalafil intake in diabetic patients with erectile dysfunction non-responding to on-demand oral PDE5 inhibitors.
Zaghloul AS; El-Nashaar AM; Said SZ; Osman IA; Mostafa T
Andrologia; 2022 Jul; 54(6):e14421. PubMed ID: 35301742
[TBL] [Abstract][Full Text] [Related]
20. A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients.
Natali A; Masieri L; Lanciotti M; Giancane S; Vignolini G; Carini M; Serni S
Int J Impot Res; 2015; 27(1):1-5. PubMed ID: 25056808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
